These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chemistry. A new route to designer antibiotics. Khosla C; Tang Y Science; 2005 Apr; 308(5720):367-8. PubMed ID: 15831747 [No Abstract] [Full Text] [Related]
3. Microbial genomics and drug discovery: exploring innovative routes of drug discovery in the postgenomic era. Dougherty TJ; Miller PF IDrugs; 2006 Jun; 9(6):420-2. PubMed ID: 16752312 [TBL] [Abstract][Full Text] [Related]
4. Structure-based drug design meets the ribosome. Franceschi F; Duffy EM Biochem Pharmacol; 2006 Mar; 71(7):1016-25. PubMed ID: 16443192 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and antibacterial activity of three palladium(II) complexes of tetracyclines. Guerra W; de Andrade Azevedo E; de Souza Monteiro AR; Bucciarelli-Rodriguez M; Chartone-Souza E; Nascimento AM; Fontes AP; Le Moyec L; Pereira-Maia EC J Inorg Biochem; 2005 Dec; 99(12):2348-54. PubMed ID: 16226807 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial spectrum, pharmacology and therapeutic use of antibiotics. Part 1: tetracyclines. Barza M; Schiefe RT Am J Hosp Pharm; 1977 Jan; 34(1):49-57. PubMed ID: 318799 [TBL] [Abstract][Full Text] [Related]
8. Molecular determinants of microbial resistance to thiopeptide antibiotics. Baumann S; Schoof S; Bolten M; Haering C; Takagi M; Shin-ya K; Arndt HD J Am Chem Soc; 2010 May; 132(20):6973-81. PubMed ID: 20441189 [TBL] [Abstract][Full Text] [Related]
9. 1,12-substituted tetracyclines as antioxidant agents. Lertvorachon J; Kim JP; Soldatov DV; Boyd J; Roman G; Cho SJ; Popek T; Jung YS; Lau PC; Konishi Y Bioorg Med Chem; 2005 Aug; 13(15):4627-37. PubMed ID: 15951186 [TBL] [Abstract][Full Text] [Related]
10. Case studies in current drug development: 'glycylcyclines'. Sum PE Curr Opin Chem Biol; 2006 Aug; 10(4):374-9. PubMed ID: 16807065 [TBL] [Abstract][Full Text] [Related]
14. A convergent enantioselective route to structurally diverse 6-deoxytetracycline antibiotics. Charest MG; Lerner CD; Brubaker JD; Siegel DR; Myers AG Science; 2005 Apr; 308(5720):395-8. PubMed ID: 15831754 [TBL] [Abstract][Full Text] [Related]
15. The folic acid biosynthesis pathway in bacteria: evaluation of potential for antibacterial drug discovery. Bermingham A; Derrick JP Bioessays; 2002 Jul; 24(7):637-48. PubMed ID: 12111724 [TBL] [Abstract][Full Text] [Related]
16. Structure-based design, synthesis and A-site rRNA co-crystal complexes of novel amphiphilic aminoglycoside antibiotics with new binding modes: a synergistic hydrophobic effect against resistant bacteria. Hanessian S; Pachamuthu K; Szychowski J; Giguère A; Swayze EE; Migawa MT; François B; Kondo J; Westhof E Bioorg Med Chem Lett; 2010 Dec; 20(23):7097-101. PubMed ID: 20970332 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial agents targeting the ribosome: the issue of selectivity and toxicity - lessons to be learned. Böttger EC Cell Mol Life Sci; 2007 Apr; 64(7-8):791-5. PubMed ID: 17429579 [No Abstract] [Full Text] [Related]
18. Viridicatumtoxin B, a new anti-MRSA agent from Penicillium sp. FR11. Zheng CJ; Yu HE; Kim EH; Kim WG J Antibiot (Tokyo); 2008 Oct; 61(10):633-7. PubMed ID: 19168978 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of a tetracycline-platinum (II) complex active against resistant bacteria. Chartone-Souza E; Loyola TL; Bucciarelli-Rodriguez M; Menezes MA; Rey NA; Pereira-Maia EC J Inorg Biochem; 2005 May; 99(5):1001-8. PubMed ID: 15833322 [TBL] [Abstract][Full Text] [Related]
20. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Chopra I; Roberts M Microbiol Mol Biol Rev; 2001 Jun; 65(2):232-60 ; second page, table of contents. PubMed ID: 11381101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]